| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovarian Neoplasms | 21 | 2013 | 467 | 1.620 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2014 | 121 | 0.730 |
Why?
|
| Carcinoma | 5 | 2012 | 305 | 0.600 |
Why?
|
| Adenocarcinoma | 6 | 2022 | 1013 | 0.540 |
Why?
|
| Breast Neoplasms | 10 | 2023 | 2750 | 0.500 |
Why?
|
| Neoplasms, Connective and Soft Tissue | 1 | 2015 | 3 | 0.490 |
Why?
|
| Chondrosarcoma | 1 | 2015 | 14 | 0.480 |
Why?
|
| Foot Diseases | 1 | 2015 | 23 | 0.480 |
Why?
|
| Fibroma | 1 | 2015 | 31 | 0.480 |
Why?
|
| Carcinoma, Endometrioid | 4 | 2011 | 16 | 0.440 |
Why?
|
| Ovary | 7 | 2010 | 386 | 0.440 |
Why?
|
| Esophageal Neoplasms | 3 | 2024 | 386 | 0.420 |
Why?
|
| Bronchoscopy | 1 | 2014 | 172 | 0.420 |
Why?
|
| Ultrasonography, Interventional | 1 | 2014 | 207 | 0.390 |
Why?
|
| Endoscopy | 1 | 2014 | 280 | 0.390 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 1558 | 0.380 |
Why?
|
| Thyroid Neoplasms | 1 | 2014 | 259 | 0.360 |
Why?
|
| Immunohistochemistry | 12 | 2018 | 1730 | 0.360 |
Why?
|
| Breast Neoplasms, Male | 1 | 2009 | 16 | 0.310 |
Why?
|
| Cell Transformation, Neoplastic | 5 | 2012 | 637 | 0.300 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2010 | 189 | 0.300 |
Why?
|
| beta Catenin | 1 | 2009 | 231 | 0.280 |
Why?
|
| MutS Homolog 2 Protein | 2 | 2006 | 39 | 0.270 |
Why?
|
| Barrett Esophagus | 2 | 2022 | 343 | 0.270 |
Why?
|
| Microsatellite Instability | 1 | 2006 | 40 | 0.260 |
Why?
|
| Epithelial Cells | 6 | 2016 | 932 | 0.250 |
Why?
|
| Biomarkers, Tumor | 9 | 2013 | 1692 | 0.250 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2006 | 12 | 0.250 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2024 | 782 | 0.240 |
Why?
|
| Tissue Array Analysis | 7 | 2011 | 143 | 0.230 |
Why?
|
| Adenocarcinoma, Mucinous | 4 | 2013 | 39 | 0.230 |
Why?
|
| Tissue Embedding | 1 | 2004 | 4 | 0.220 |
Why?
|
| Cystadenocarcinoma, Serous | 4 | 2013 | 58 | 0.220 |
Why?
|
| Tumor Microenvironment | 2 | 2021 | 699 | 0.210 |
Why?
|
| Influenza, Human | 1 | 2010 | 700 | 0.210 |
Why?
|
| Esophagoscopy | 1 | 2024 | 163 | 0.210 |
Why?
|
| Microscopy | 1 | 2024 | 123 | 0.210 |
Why?
|
| Lung | 1 | 2010 | 1570 | 0.190 |
Why?
|
| Telomerase | 4 | 2012 | 169 | 0.190 |
Why?
|
| Adenocarcinoma, Clear Cell | 4 | 2013 | 25 | 0.190 |
Why?
|
| Neoplasm Staging | 7 | 2018 | 1363 | 0.190 |
Why?
|
| Humans | 48 | 2024 | 133147 | 0.180 |
Why?
|
| Carrier Proteins | 2 | 2006 | 1071 | 0.180 |
Why?
|
| Prognosis | 8 | 2023 | 5030 | 0.180 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2023 | 338 | 0.180 |
Why?
|
| Veterans | 3 | 2022 | 1782 | 0.180 |
Why?
|
| Sensitivity and Specificity | 3 | 2014 | 2139 | 0.180 |
Why?
|
| Middle Aged | 19 | 2024 | 28911 | 0.180 |
Why?
|
| Female | 37 | 2024 | 71382 | 0.170 |
Why?
|
| Receptors, Estrogen | 5 | 2008 | 829 | 0.170 |
Why?
|
| Cell Degranulation | 1 | 2020 | 28 | 0.170 |
Why?
|
| Early Detection of Cancer | 1 | 2024 | 413 | 0.170 |
Why?
|
| Nuclear Proteins | 2 | 2006 | 1340 | 0.170 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2008 | 2125 | 0.170 |
Why?
|
| Precancerous Conditions | 2 | 2022 | 254 | 0.170 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2020 | 29 | 0.170 |
Why?
|
| Duodenum | 1 | 2020 | 97 | 0.160 |
Why?
|
| Eosinophils | 1 | 2020 | 108 | 0.160 |
Why?
|
| Dyspepsia | 1 | 2020 | 103 | 0.160 |
Why?
|
| Eosinophilia | 1 | 2020 | 86 | 0.160 |
Why?
|
| Carcinoma, Transitional Cell | 2 | 2013 | 186 | 0.160 |
Why?
|
| Aged | 15 | 2024 | 21446 | 0.150 |
Why?
|
| Sulfur-Reducing Bacteria | 1 | 2018 | 2 | 0.150 |
Why?
|
| Colitis, Microscopic | 1 | 2018 | 4 | 0.150 |
Why?
|
| Aged, 80 and over | 9 | 2018 | 7137 | 0.150 |
Why?
|
| Health Information Systems | 1 | 2019 | 35 | 0.150 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2012 | 45 | 0.150 |
Why?
|
| Adult | 17 | 2020 | 31608 | 0.150 |
Why?
|
| Thrombocytopenia | 1 | 2020 | 235 | 0.140 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2021 | 453 | 0.140 |
Why?
|
| Interleukin-17 | 1 | 2018 | 130 | 0.140 |
Why?
|
| Biopsy | 3 | 2024 | 1201 | 0.130 |
Why?
|
| CELF1 Protein | 1 | 2016 | 50 | 0.130 |
Why?
|
| Fibrin | 1 | 2016 | 64 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2007 | 216 | 0.120 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2016 | 249 | 0.120 |
Why?
|
| Oncolytic Viruses | 1 | 2016 | 76 | 0.120 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 425 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 385 | 0.110 |
Why?
|
| Male | 13 | 2024 | 65472 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 395 | 0.110 |
Why?
|
| Cell Movement | 3 | 2016 | 906 | 0.110 |
Why?
|
| Image-Guided Biopsy | 1 | 2014 | 43 | 0.110 |
Why?
|
| Nephrotic Syndrome | 2 | 2005 | 52 | 0.110 |
Why?
|
| Disease-Free Survival | 3 | 2014 | 965 | 0.110 |
Why?
|
| Polyethylene Glycols | 1 | 2016 | 254 | 0.110 |
Why?
|
| RNA, Small Interfering | 5 | 2008 | 720 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2010 | 1325 | 0.110 |
Why?
|
| Neoplasm, Residual | 1 | 2014 | 134 | 0.100 |
Why?
|
| Mice, Nude | 4 | 2012 | 780 | 0.100 |
Why?
|
| CA-125 Antigen | 1 | 2013 | 15 | 0.100 |
Why?
|
| Oncogenes | 1 | 2014 | 181 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 3041 | 0.100 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2014 | 1136 | 0.100 |
Why?
|
| Adenoviridae | 1 | 2016 | 604 | 0.100 |
Why?
|
| Homeodomain Proteins | 2 | 2007 | 584 | 0.100 |
Why?
|
| Hemorrhage | 2 | 2020 | 519 | 0.100 |
Why?
|
| Models, Biological | 2 | 2016 | 1530 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 1 | 2014 | 562 | 0.090 |
Why?
|
| Endometrial Neoplasms | 1 | 2013 | 115 | 0.090 |
Why?
|
| Feasibility Studies | 1 | 2014 | 823 | 0.090 |
Why?
|
| Fallopian Tubes | 1 | 2012 | 78 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2014 | 452 | 0.090 |
Why?
|
| Cell Line, Tumor | 7 | 2016 | 3794 | 0.090 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 511 | 0.090 |
Why?
|
| BRCA2 Protein | 1 | 2011 | 50 | 0.090 |
Why?
|
| Carcinogenesis | 1 | 2014 | 361 | 0.090 |
Why?
|
| Cell Line, Transformed | 2 | 2012 | 165 | 0.090 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2008 | 93 | 0.090 |
Why?
|
| DNA Damage | 1 | 2014 | 517 | 0.090 |
Why?
|
| Tracheitis | 1 | 2010 | 14 | 0.090 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2018 | 822 | 0.080 |
Why?
|
| Mice | 10 | 2023 | 18930 | 0.080 |
Why?
|
| Autopsy | 1 | 2010 | 117 | 0.080 |
Why?
|
| Necrosis | 1 | 2010 | 210 | 0.080 |
Why?
|
| Mitotic Index | 1 | 2009 | 18 | 0.080 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 1964 | 0.080 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2023 | 145 | 0.080 |
Why?
|
| Peritoneum | 1 | 2010 | 40 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2024 | 2286 | 0.080 |
Why?
|
| Disease Progression | 3 | 2022 | 2241 | 0.080 |
Why?
|
| Pulmonary Alveoli | 1 | 2010 | 142 | 0.080 |
Why?
|
| Autophagy | 2 | 2014 | 431 | 0.080 |
Why?
|
| Transfection | 3 | 2007 | 1095 | 0.080 |
Why?
|
| Antigens, CD | 1 | 2011 | 441 | 0.080 |
Why?
|
| MutL Protein Homolog 1 | 2 | 2006 | 52 | 0.080 |
Why?
|
| Bronchiolitis | 1 | 2010 | 123 | 0.080 |
Why?
|
| Glycoproteins | 1 | 2011 | 381 | 0.080 |
Why?
|
| Carcinoma, Papillary | 1 | 2010 | 96 | 0.080 |
Why?
|
| Annexin A1 | 1 | 2008 | 6 | 0.080 |
Why?
|
| Aldehyde Dehydrogenase | 1 | 2009 | 45 | 0.080 |
Why?
|
| Kidney Transplantation | 2 | 2005 | 574 | 0.080 |
Why?
|
| Animals | 12 | 2023 | 36189 | 0.070 |
Why?
|
| Isoenzymes | 1 | 2009 | 228 | 0.070 |
Why?
|
| RNA, Viral | 1 | 2010 | 562 | 0.070 |
Why?
|
| Retrospective Studies | 7 | 2022 | 17520 | 0.070 |
Why?
|
| Peptides | 1 | 2011 | 863 | 0.070 |
Why?
|
| Proteinuria | 2 | 2005 | 111 | 0.070 |
Why?
|
| Breast | 1 | 2009 | 218 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2007 | 616 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2650 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2009 | 483 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2016 | 6570 | 0.070 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2007 | 53 | 0.070 |
Why?
|
| Gene Products, env | 1 | 2007 | 17 | 0.070 |
Why?
|
| Endogenous Retroviruses | 1 | 2007 | 20 | 0.070 |
Why?
|
| Neoplasm Invasiveness | 3 | 2016 | 674 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2013 | 1310 | 0.060 |
Why?
|
| Cell Nucleus | 1 | 2009 | 689 | 0.060 |
Why?
|
| Gene Expression | 2 | 2008 | 1608 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2006 | 13 | 0.060 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 12 | 0.060 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 5 | 1 | 2006 | 8 | 0.060 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 2 | 1 | 2006 | 11 | 0.060 |
Why?
|
| Retinoblastoma Protein | 1 | 2006 | 85 | 0.060 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2006 | 78 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2008 | 456 | 0.060 |
Why?
|
| Receptors, Progesterone | 2 | 2008 | 899 | 0.060 |
Why?
|
| Antigens, Viral, Tumor | 1 | 2006 | 47 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2006 | 118 | 0.060 |
Why?
|
| Prostatic Hyperplasia | 1 | 2006 | 118 | 0.060 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2008 | 592 | 0.060 |
Why?
|
| Acetyltransferases | 1 | 2005 | 93 | 0.060 |
Why?
|
| CpG Islands | 1 | 2007 | 347 | 0.060 |
Why?
|
| Survival Rate | 4 | 2013 | 2204 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2006 | 625 | 0.060 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2006 | 69 | 0.060 |
Why?
|
| Comorbidity | 1 | 2010 | 1620 | 0.060 |
Why?
|
| Oncogene Proteins | 1 | 2005 | 157 | 0.060 |
Why?
|
| Signal Transduction | 3 | 2014 | 4915 | 0.060 |
Why?
|
| Mullerian Ducts | 1 | 2005 | 46 | 0.060 |
Why?
|
| Iodides | 1 | 2024 | 15 | 0.060 |
Why?
|
| Simian virus 40 | 1 | 2006 | 196 | 0.060 |
Why?
|
| Coloring Agents | 1 | 2024 | 73 | 0.060 |
Why?
|
| Myosin Type IV | 1 | 2004 | 1 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 445 | 0.060 |
Why?
|
| Biomarkers | 2 | 2018 | 3411 | 0.060 |
Why?
|
| Tissue Fixation | 1 | 2004 | 40 | 0.050 |
Why?
|
| Ki-67 Antigen | 1 | 2004 | 118 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2010 | 1710 | 0.050 |
Why?
|
| China | 1 | 2024 | 292 | 0.050 |
Why?
|
| Cell Proliferation | 3 | 2016 | 2559 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 3 | 2011 | 252 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2015 | 3863 | 0.050 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2004 | 75 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2014 | 1405 | 0.050 |
Why?
|
| Amino Acid Transport System y+L | 1 | 2023 | 17 | 0.050 |
Why?
|
| Printing, Three-Dimensional | 1 | 2024 | 70 | 0.050 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2008 | 541 | 0.050 |
Why?
|
| Microsatellite Repeats | 1 | 2004 | 238 | 0.050 |
Why?
|
| Kenya | 1 | 2023 | 63 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 1582 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2023 | 3978 | 0.050 |
Why?
|
| Robotics | 1 | 2024 | 110 | 0.050 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2023 | 115 | 0.050 |
Why?
|
| Equipment Design | 1 | 2024 | 604 | 0.050 |
Why?
|
| United States | 3 | 2024 | 11711 | 0.050 |
Why?
|
| Texas | 1 | 2010 | 3664 | 0.050 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2023 | 159 | 0.050 |
Why?
|
| Point-of-Care Systems | 1 | 2024 | 194 | 0.050 |
Why?
|
| Growth Disorders | 1 | 2023 | 223 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2005 | 835 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2022 | 195 | 0.040 |
Why?
|
| Neoplasms | 1 | 2016 | 2984 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 3734 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 624 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2023 | 4755 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2007 | 2719 | 0.040 |
Why?
|
| DNA Methylation | 1 | 2007 | 1139 | 0.040 |
Why?
|
| Neoplasm Metastasis | 2 | 2018 | 741 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2006 | 3131 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 712 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2004 | 788 | 0.040 |
Why?
|
| Aurora Kinases | 2 | 2011 | 27 | 0.040 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2021 | 223 | 0.040 |
Why?
|
| Drosophila | 1 | 2004 | 828 | 0.040 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2020 | 151 | 0.040 |
Why?
|
| Software | 1 | 2024 | 732 | 0.040 |
Why?
|
| Combined Modality Therapy | 2 | 2014 | 1307 | 0.040 |
Why?
|
| Aurora Kinase A | 2 | 2011 | 37 | 0.040 |
Why?
|
| Actinomyces | 1 | 2018 | 4 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2007 | 1610 | 0.040 |
Why?
|
| Actinobacteria | 1 | 2018 | 13 | 0.040 |
Why?
|
| Bacillus | 1 | 2018 | 37 | 0.040 |
Why?
|
| Goals | 1 | 2019 | 134 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2024 | 683 | 0.040 |
Why?
|
| Smad4 Protein | 1 | 2018 | 59 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 341 | 0.030 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 357 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2018 | 345 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2018 | 100 | 0.030 |
Why?
|
| Developing Countries | 1 | 2019 | 290 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 1602 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2018 | 403 | 0.030 |
Why?
|
| Public Health | 1 | 2019 | 283 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 306 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2018 | 3406 | 0.030 |
Why?
|
| Lymphatic Metastasis | 2 | 2008 | 449 | 0.030 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 258 | 0.030 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 313 | 0.030 |
Why?
|
| Colonoscopy | 1 | 2018 | 233 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2016 | 105 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2010 | 1136 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2016 | 2876 | 0.030 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2016 | 29 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 223 | 0.030 |
Why?
|
| Risk Factors | 2 | 2022 | 10930 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2018 | 619 | 0.030 |
Why?
|
| Proton Pump Inhibitors | 1 | 2018 | 275 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 2 | 2010 | 562 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2004 | 2144 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2016 | 108 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2007 | 1097 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 834 | 0.030 |
Why?
|
| Infant | 1 | 2010 | 13235 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2016 | 614 | 0.030 |
Why?
|
| Cyclin E | 1 | 2014 | 33 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2016 | 314 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 2628 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 884 | 0.030 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 398 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2023 | 4823 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2016 | 677 | 0.030 |
Why?
|
| Macrophages | 1 | 2018 | 697 | 0.030 |
Why?
|
| Mammary Glands, Human | 1 | 2014 | 84 | 0.030 |
Why?
|
| Young Adult | 3 | 2013 | 9917 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 899 | 0.030 |
Why?
|
| Organoids | 1 | 2016 | 301 | 0.020 |
Why?
|
| PAX8 Transcription Factor | 1 | 2012 | 16 | 0.020 |
Why?
|
| Pandemics | 1 | 2020 | 1192 | 0.020 |
Why?
|
| Keratins | 1 | 2012 | 52 | 0.020 |
Why?
|
| Graft Survival | 2 | 2005 | 482 | 0.020 |
Why?
|
| Paired Box Transcription Factors | 1 | 2012 | 77 | 0.020 |
Why?
|
| Neoplasm Grading | 1 | 2013 | 306 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 2012 | 88 | 0.020 |
Why?
|
| Base Sequence | 2 | 2007 | 3153 | 0.020 |
Why?
|
| Risk | 1 | 2014 | 781 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2014 | 404 | 0.020 |
Why?
|
| AC133 Antigen | 1 | 2011 | 37 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2020 | 3087 | 0.020 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 3960 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2012 | 177 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 5188 | 0.020 |
Why?
|
| Inflammation | 1 | 2018 | 1556 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 1467 | 0.020 |
Why?
|
| Quality of Life | 1 | 2020 | 2160 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2010 | 74 | 0.020 |
Why?
|
| Genomics | 1 | 2018 | 1672 | 0.020 |
Why?
|
| Apoptosis | 2 | 2007 | 1928 | 0.020 |
Why?
|
| Retinal Dehydrogenase | 1 | 2009 | 12 | 0.020 |
Why?
|
| Connexin 26 | 1 | 2008 | 13 | 0.020 |
Why?
|
| Connexins | 1 | 2008 | 64 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 149 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2008 | 170 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2008 | 238 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2008 | 187 | 0.020 |
Why?
|
| Genes, BRCA2 | 1 | 2007 | 49 | 0.020 |
Why?
|
| Genes, BRCA1 | 1 | 2007 | 61 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2007 | 125 | 0.020 |
Why?
|
| Genes, Homeobox | 1 | 2007 | 72 | 0.020 |
Why?
|
| Ovariectomy | 1 | 2007 | 189 | 0.020 |
Why?
|
| Carcinoma, Lobular | 1 | 2007 | 26 | 0.020 |
Why?
|
| Tumor Necrosis Factor Decoy Receptors | 1 | 2006 | 1 | 0.020 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2006 | 43 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2006 | 103 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2007 | 432 | 0.020 |
Why?
|
| Karyotyping | 1 | 2006 | 321 | 0.020 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2005 | 26 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2007 | 301 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2006 | 180 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 4575 | 0.020 |
Why?
|
| Calpain | 1 | 2006 | 43 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 1067 | 0.010 |
Why?
|
| Genomic Imprinting | 1 | 2006 | 130 | 0.010 |
Why?
|
| Histone Acetyltransferases | 1 | 2005 | 319 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 670 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2008 | 1706 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2007 | 814 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 2004 | 36 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2005 | 470 | 0.010 |
Why?
|
| Cell Size | 1 | 2004 | 87 | 0.010 |
Why?
|
| DNA Primers | 1 | 2005 | 656 | 0.010 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2009 | 829 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 5434 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 2004 | 399 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 713 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2005 | 351 | 0.010 |
Why?
|
| Creatinine | 1 | 2005 | 416 | 0.010 |
Why?
|
| Telomere | 1 | 2004 | 227 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 1420 | 0.010 |
Why?
|
| Cell Division | 1 | 2004 | 765 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2007 | 2784 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 2005 | 494 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2005 | 1236 | 0.010 |
Why?
|
| Cell Line | 1 | 2005 | 2855 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2006 | 2521 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2005 | 771 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2009 | 1849 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2005 | 2026 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 3360 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 6541 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 6340 | 0.010 |
Why?
|
| Adolescent | 1 | 2004 | 20528 | 0.000 |
Why?
|